| Mortality results from a randomized prostate-cancer screening trial GL Andriole, ED Crawford, RL Grubb III, SS Buys, D Chia, TR Church, ... New England journal of medicine 360 (13), 1310-1319, 2009 | 3897 | 2009 |
| Natural history of progression after PSA elevation following radical prostatectomy CR Pound, AW Partin, MA Eisenberger, DW Chan, JD Pearson, PC Walsh Jama 281 (17), 1591-1597, 1999 | 3770 | 1999 |
| Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update AW Partin, MW Kattan, ENP Subong, PC Walsh, KJ Wojno, JE Oesterling, ... Jama 277 (18), 1445-1451, 1997 | 2536 | 1997 |
| Campbell-Walsh Urology E-Book: 4-Volume Set AJ Wein, LR Kavoussi, AW Partin, CA Peters Elsevier Health Sciences, 2015 | 2332 | 2015 |
| Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC Flanigan, A Patel, ... Jama 279 (19), 1542-1547, 1998 | 1757 | 1998 |
| The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer AW Partin, J Yoo, HB Carter, JD Pearson, DW Chan, JI Epstein, PC Walsh The Journal of urology 150 (1), 110-114, 1993 | 1663 | 1993 |
| Risk of prostate cancer–specific mortality following biochemical recurrence after radical prostatectomy SJ Freedland, EB Humphreys, LA Mangold, M Eisenberger, FJ Dorey, ... Jama 294 (4), 433-439, 2005 | 1652 | 2005 |
| Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium AW Partin, LA Mangold, DM Lamm, PC Walsh, JI Epstein, JD Pearson Urology 58 (6), 843-848, 2001 | 1472 | 2001 |
| Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience M Han, AW Partin, CR Pound, JI Epstein, PC Walsh Urologic Clinics of North America 28 (3), 555-565, 2001 | 1336 | 2001 |
| Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer R Hu, TA Dunn, S Wei, S Isharwal, RW Veltri, E Humphreys, M Han, ... Cancer research 69 (1), 16-22, 2009 | 1299 | 2009 |
| Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 J Gudmundsson, P Sulem, A Manolescu, LT Amundadottir, ... Nature genetics 39 (5), 631-637, 2007 | 1008 | 2007 |
| Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer M Han, AW Partin, M Zahurak, S Piantadosi, JI Epstein, PC Walsh The Journal of urology 169 (2), 517-523, 2003 | 990 | 2003 |
| Prostate specific antigen: a decade of discovery-what we have learned and where we are going TJ Polascik, JE Oesterling, AW Partin The Journal of urology 162 (2), 293-306, 1999 | 950 | 1999 |
| Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years PC Walsh, AW Partin, JI Epstein The Journal of urology 152 (5), 1831-1836, 1994 | 925 | 1994 |
| Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia AW Partin, HB Carter, DW Chan, JI Epstein, JE Oesterling, RC Rock, ... The Journal of urology 143 (4), 747-752, 1990 | 873 | 1990 |
| Prognostic G leason grade grouping: data based on the modified G leason scoring system PM Pierorazio, PC Walsh, AW Partin, JI Epstein BJU international 111 (5), 753-760, 2013 | 848 | 2013 |
| Germline Mutations in HOXB13 and Prostate-Cancer Risk CM Ewing, AM Ray, EM Lange, KA Zuhlke, CM Robbins, WD Tembe, ... New England Journal of Medicine 366 (2), 141-149, 2012 | 804 | 2012 |
| Prostate-specific antigen after anatomic radical retropubic prostatectomy: patterns of recurrence and cancer control CR Pound, AW Partin, JI Epstein, PC Walsh Urologic Clinics of North America 24 (2), 395-406, 1997 | 789 | 1997 |
| Prostate cancer–specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy BJ Trock, M Han, SJ Freedland, EB Humphreys, TL DeWeese, AW Partin, ... Jama 299 (23), 2760-2769, 2008 | 784 | 2008 |
| Predicting 15-year prostate cancer specific mortality after radical prostatectomy SE Eggener, PT Scardino, PC Walsh, M Han, AW Partin, BJ Trock, Z Feng, ... The Journal of urology 185 (3), 869-875, 2011 | 758 | 2011 |
Jonathan EpsteinJohns Hopkins Medical Institutions在 jhmi.edu 的电子邮件经过验证
